Jan 29, 2026 09:15AM
Jan 29, 2026 07:05AM
Jan 29, 2026 07:05AM
Dec 29, 2025 07:05AM
Dec 29, 2025 07:05AM
Dec 2, 2025 12:39PM
Nov 12, 2025 08:36AM Unicycive Therapeutics (UNCY) PT Lowered to $63 at Lucid Capital Markets
Nov 12, 2025 07:05AM
Oct 28, 2025 07:06AM
Oct 28, 2025 07:05AM
Jun 11, 2025 06:38AM
Jun 10, 2025 06:02AM
Jun 10, 2025 06:00AM
May 21, 2025 08:48AM Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics (UNCY)
May 14, 2025 07:15AM
Apr 10, 2025 09:14AM
Apr 10, 2025 08:00AM
Apr 1, 2025 07:00AM
Apr 1, 2025 06:46AM
Mar 31, 2025 07:00AM
Mar 13, 2025 07:00AM Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing Oxylanthanum Carbonate Reduced Pill Burden and Improved Adherence in Treatment of Hyperphosphatemia
Feb 20, 2025 07:02AM
Feb 20, 2025 07:00AM
Jan 28, 2025 07:02AM
Jan 28, 2025 07:00AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM
Dec 17, 2024 07:00AM Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
Nov 21, 2024 07:00AM
Nov 13, 2024 07:15AM
Nov 12, 2024 07:52AM
Nov 11, 2024 07:01AM
Nov 11, 2024 07:00AM
Sep 7, 2024 08:00PM
Sep 4, 2024 07:27AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Sep 3, 2024 07:03AM
Sep 3, 2024 07:03AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All